Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study

Table 5 Risks of incident diabetes based on different glucose intolerance states. (n = 361)

	HR	Model 1	P value	HR	Model 2	P value
		95%(CI)			95%(CI)
FPG and 2 h-PCPG categories
IFG-WHO	2.79	1.78–4.37	< 0.001	2.28	1.44–3.63	< 0.001
IFG-ADA	2.46	1.75–3.46	< 0.001	2.37	1.66–3.37	< 0.001
IGT	2.94	2.09–4.12	< 0.001	2.67	1.87–3.79	< 0.001
Per 1-SD increase
FPG	12.82	6.18–26.60	< 0.001	9.90	4.67–20.98	< 0.001
2 h-PCPG	3.20	2.39–4.29	< 0.001	2.79	2.05–3.79	< 0.001

HR hazard ratio, CI confidence interval, IFG impaired fasting glucose, IGT impaired glucose tolerance, WHO World Health Organization, ADA American Diabetes Association, FPG fasting plasma glucose, 2 h-PCPG 2 h post challenge plasma glucose
Model 1: age and sex
Model 2: model 1 plus family history of diabetes, body mass index, low physical activity, hypertriglyceridemia and low HDL-C

ISSN: 1479-5876